To observe the effectiveness and safety of different therapies-non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) or antiplatelet agents and non-antithrombotic therapy - for the treatment of VT.
Study Type
OBSERVATIONAL
Enrollment
480
Collecting information of patients with VT who received NOACs
Collecting information of patients with VT who received VKAs
Collecting information of patients with VT who received antiplatelet agents
Qing Yang
Beijing, China
RECRUITINGThrombus resolution in 12 weeks follow-up
Thrombus resolution in 12 weeks follow-up
Time frame: 12 weeks
Thrombus resolution in 6 weeks follow-up
Thrombus resolution in 6 weeks follow-up
Time frame: 6 weeks
Thrombus resolution in 6 months follow-up
Thrombus resolution in 6 months follow-up
Time frame: 6 months
Thrombus resolution in 12 months follow-up
Thrombus resolution in 12 months follow-up
Time frame: 12 months
Thromboembolism events
Thromboembolism events
Time frame: 12 months
Bleeding
Bleeding
Time frame: 12 months
All-cause death
All-cause death
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Collecting information of patients with VT without any antithrombotic therapy